Good day, ladies and gentlemen, and welcome to Consensus Cloud Solutions Q2 2024 earnings call. My name is Paul, and I will be the operator assisting you today. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. On this call from Consensus Cloud Solutions will be Scott Turicchi, CEO; Jim Malone, CFO; Johnny Hecker, CRO, and Executive Vice President of Operations; and Adam Varon, Senior Vice President of Finance. I will now turn the call over to Adam Varon, Senior Vice President of Finance at Consensus Cloud Solutions. Thank you. You may begin. Good afternoon, and welcome to the Consensus investor call to discuss our Q2 2024 financial results, other key information, our Q3 2024 quarterly guidance, and full year 2024 guidance. Joining me today are Scott Turicchi, CEO, Johnny Hecker, CRO, and EVP of Operations, and Jim Malone, CFO. The earnings call will begin with Scott providing opening remarks. Johnny will give an update on operational progress since our Q1 2024 investor call, and then Jim will discuss Q2 2024 financial results, our Q3 2024 quarterly and full year 2024 guidance. After we finish our prepared remarks, we will conduct a Q&A session. At that time, the operator will instruct you on the procedures for asking a question. Before we begin our prepared remarks, allow me to direct you to our forward-looking statements and risk factors on slide two. As you know, this call and the webcast will include forward-looking statements. Such statements may involve risks and uncertainties that would cause actual results to differ materially from the anticipated results. Some of those risks and uncertainties include, but are not limited to, the risk factors that we have disclosed in our 10-K SEC filing. Now, let me turn the call over to Scott. Thank you, Adam. We had a strong Q2 outperforming on both channels of revenue, Adjusted EBITDA, Adjusted Earnings, Adjusted EPS, and Free Cash Flow. As we laid out in our Q4 earnings call, our goals for this year include the following: First, eliminating certain costs of the SoHo channel, especially in the area of marketing, to provide for stabilization of the base of revenue over time. Second, continuing to pursue the acquisition of customers, primarily in the healthcare space, for our corporate channel. Third, reviewing and improving our overall cost structure with the goal of driving Adjusted EBITDA margins to the higher end of our 50%-55% range. And fourth, continuing to repurchase our debt to further reduce our total debt to Adjusted EBITDA ratio in anticipation of the first tranche maturing in October 2026. Let me provide a few additional highlights before turning the call over to Johnny. Our corporate channel continued to add new customers, primarily through upgrades from our SoHo base, as well as our relatively new e-commerce offering, eFax Protect. Notwithstanding the lower ARPA of these customers than our current average, we were still able to maintain a $310 ARPA and a tight range over the past several quarters of between $305 and $320. We continue to see additional sites from the VA rolling out, driving new levels of usage and revenue. Our SoHo revenues beat our expectations for the quarter. I would remind you that in Q2 2023, we finished the price increase to our base and actually saw a slight growth in revenues versus Q2 2022. As we stated at the time, we viewed this growth as anomalous. We continue to track ahead of our 2023 budget and have found additional marketing opportunities while maintaining a strong LTV to CAC. We were able to substantially reduce our marketing spend and still generate 61,000 paid ads, more than Q4 2023, and similar to Q3 2023, which had higher levels of spend. Our cost structure benefited from a full quarter of the cost optimization that we discussed on our Q4 call. As a reminder, most of those cost reductions came primarily from the SoHo marketing mentioned earlier. The result was a 4.7 percentage point pickup on our adjusted EBITDA margin to 56.1% for the quarter, which is above the upper end of our long-term range. The combination of improved Adjusted EBITDA, strong cash collections, and retirement of debt allowed us to improve our Free Cash Flow by more than $11 million from Q2 2023. We were able to repurchase an additional $29.7 million of debt during the quarter. This brings our total repurchases since launching the program in November 2023 to $156 million, and reducing our outstanding total debt to $649 million, or 3.4x our trailing twelve-month Adjusted EBITDA, and 3.1x on a net debt basis. I will now turn the call over to Johnny, who will provide you more operating details. Thank you, Scott, and hello, everyone. Today, I will share business and go-to-market updates covering both our corporate and SoHo businesses, along with more details on the public sector, specifically the VA rollout and some product enhancements. Let's start by sharing our sales and operations update, another solid performance in the corporate business. We are pleased to report revenue of $51.7 million versus $50.4 million last year for Q2, marking an approximate 3% increase over the same period last year. This outcome serves as a testament to use cases for Cloud Fax in corporate settings, especially in healthcare. I am most pleased with the increase in the variable portion of our revenues, indicating mostly upmarket growth. It marks another record-setting quarter for our corporate business, emphasizing the unwavering strength and effectiveness of our offerings. The e-commerce and SOHO upsell strategy continues to be a valuable source of customer acquisition, with approximately 2,700 customers added in Q2, demonstrating the effectiveness of our strategy. During the last call, we projected a decline in our SoHo to corporate upsell during Q2 due to planned operational changes. However, the growth of our eFax Protect service helped us offset this slowdown to a large extent. We will continue to invest in and expand this e-commerce offering, which aligns with the go-to-market realignment strategy we shared last year. The next phase of this offering will include in-product upsell options for our customers, eliminating the need for in-person interaction with customers for that process. The metrics we share reveal that the growth in corporate accounts, driven by those new customers at the lower end of our customer continuum, also leads to a higher corporate cancellation rate. It has increased by 103 basis points year-over-year, and 37 basis points quarter-over-quarter, reaching 2.29% in the second quarter of 2024. Normalized for eFax Protect, the cancel rate in corporate remains significantly below the 2% mark. I would remind you that our cancellation rate is based on accounts and not on revenue. We foresaw this trend with the launch of the e-commerce channel and are pleased to report that corporate ARPA has remained steady for several quarters within the $305-$320 range, at just above $310 this quarter. During Q2, advanced products accounted for 14% of new sales, aligning with the performance of the second half of the last year, while being lower than the Q1 contribution. This temporary slowdown is mainly attributed to our Unite offering after a strong sales performance in Q1. It's important to note that this percentage fluctuates and is also influenced by the new sales of our core fax services. Overall, we're on track with the execution of our go-to-market plan in 2024. We're increasingly closing customers in the lower ARPA spectrum through fully automated e-commerce processes, allowing for our sales team to focus on larger deals, driving up overall sales productivity. I'd also like to highlight our public sector business. The implementation of ECFax at the VA is proceeding as planned, and our enthusiasm for its potential remains unwavering. We are observing steady growth in line with our projections, and we confidently confirm that we forecast more than $2 million in revenue from the ECFax program in 2024, and expect continued growth in the coming months and years as we move forward. ECFax stands out as the sole Cloud Fax solution on the FedRAMP marketplace, with the additional exceptional distinction of complying with the high impact level controls. This attests to the utmost level of security, integrity, and availability, vital for government agencies operating in sensitive sectors like law enforcement, healthcare, finance, and defense. As we advance our relationships with these agencies, it becomes increasingly apparent that meeting the FedRAMP high impact standard is a prerequisite for even being considered as a potential solution by the government. We are pleased to share that discussions with other agencies are proceeding. We're witnessing heightened demand for our solutions in a second relevant area of the public sector: state and local government and education. This prompts us to explore strengthening our emphasis on the public sector as a critical pillar in our corporate business beyond healthcare and commercial, as we approach our 2025 planning process. Regarding our core fax business, we remain committed to investing in the ongoing development and enhancement of our Cloud Fax platform. Adopting a fully cloudified approach has demonstrated to be the optimal strategy, particularly in terms of scalability, resilience, and innovation. We consistently strive to enhance the platform, keeping our customers' best interests at the forefront while ensuring our continued economic success. We continue to receive robust interest in our AI offering, Clarity, which leverages our proprietary LLM and related technologies to unlock valuable insights from unstructured data. Customers and potential clients are particularly intrigued by the possibility of tailoring Clarity's models to their specific use cases, enabling them to extract actionable intelligence and automate workflows in ways never before possible. This heightened interest is reflected in the growing number of proof of concept requests, which are currently contributing to our expanding implementation backlog. Turning to our SoHo business, Q2 revenue was $35.8 million versus $42.4 million previous year. Consistent with the focused marketing changes we announced last year, the total SoHo account base has decreased from 808,000- 785,000 during the quarter. Similar to last quarter, we again remained slightly ahead of expectations, with a continued reduction in free trials and the majority of customers signing up for a first-month discounted price plan, allowing us to increase revenue velocity inside the customer population. We see ARPA stable at $14.97 in Q2, while the cancel rate is improving slightly to 3.4% sequentially and improved from 3.57% in Q2 of the previous year. Our smarter ad spend strategy, which centers around boosting profitability in customer acquisition, continues to yield positive results. We have successfully automated and optimized this program, leading to improved outcomes. Coupled with robust organic returns from our SEO initiatives and our refreshed eFax web presence, we are pleased to report that the SoHo business is meeting the intended objectives and marginally outperforming expectations, as evidenced by certain stable key metrics. As a result, we expect to nominally increase our marketing spend using this new approach in the second half of 2024 by approximately $2 million. This concludes my update on our SoHo business. In closing, in light of ongoing economic uncertainty, cost awareness, and limited IT resources for our customers and prospects, their decision-making processes remain slow. To navigate these challenging market conditions, we maintain a high level of flexibility in our go-to-market approach and prioritize sales efficiency. We remain committed to our strategy with a strong focus on cash generation and profitability, while our go-to-market efforts will continue to center on driving growth within the corporate business. And now I'll hand the call over to our CFO, Jim Malone, who will provide further details about our financial results and guidance. Thank you, Johnny, and good afternoon, everyone. In our press release and on this earnings call today, we are discussing Q2 2024 results and Q3 2024 guidance. We are reaffirming full year 2024 revenue and adjusted EBITDA guidance, while increasing our full year adjusted EPS guidance range. We expect to file the 10-Q today. Let's start with our corporate business results. Q2 2024 revenue was a record at $51.7 million, an increase of $1.4 million or 2.7% over the prior year, and performing in line with our expectations. Corporate ARPA of $310, down from $317 or 2% in the prior year, and in line with the last several quarters, ranging from $305- $320. Q2 2024 customer churn of 2.29% increased 103 basis points year-over-year and 37 basis points sequentially, primarily driven by new customers at the lower end of our customer continuum. As Johnny mentioned in his script, normalized for the eFax Protect product, the cancel rate would have been below 2%. Notwithstanding this, these customers are net economically beneficial, and I would also remind you that our cancel rate is based upon customers, not revenue. Corporate delivered a trailing twelve-month revenue retention of 99%, an improvement over Q1 2024. Moving to SoHo, Q2 2024 revenue of $35.8 million is a decrease of $6.7 million or 15.8% over the prior year, and better than our expectations. The year-over-year decrease was driven by planned reduced advertising spend and year-over-year base reduction due to fewer paid ads. With an increase of $0.2 sequentially, ARPA of $14.97 decreased 4.6% year-over-year as a result of shifting to price plans with a discounted first month versus a free trial, resulting in higher paid ads in the quarter. These plans are net economically beneficial. Churn declined 17 basis points to 3.4% year-over-year and was in line with expectations. As you recall, Q2 2023 was the final quarter of our price increase cycle. Moving to Q2 consolidated results, revenue of $87.5 million is a decrease of $5.3 million or 5.7% over Q2 2023, in line with our expectations and driven by the planned reduction in SoHo revenue. Adjusted EBITDA of $49.1 million, an increase of $1.4 million or 2.9% over Q2 2023, was driven by the cost structure optimization, primarily in the area of SoHo advertising. Adjusted EBITDA margin of 56.1% was 4.7 points above the prior year, exceeding expectations at the high end of our range, which is 55%. Adjusted net income of $28.1 million is an increase of $1.3 million, or 4.9% over the prior year, driven by adjusted EBITDA flow-through and net interest expense as a result of the bond repurchase activity, offset by higher D&A and income tax expense. Adjusted EPS of $1.45 is higher than the prior year by 6.6% or $0.09, driven by the items I mentioned and a modestly lower share count. Q2 2024 non-GAAP tax rate and share count was 21.3% and 19.3 million shares, both consistent with our Q2 guidance. Let's talk about our capital allocation strategy. As mentioned in our Q3 November 2023 earnings call, we announced a $300 million three-year bond repurchase program. In Q2 2024, we repurchased approximately $30 million face value for $28 million in cash. Program to date, we've repurchased $156 million face value for $143 million in cash. We have approximately $144 million remaining under this program. Total debt to adjusted EBITDA leverage with the debt repurchases mentioned, our debt to adjusted EBITDA ratio is 3.1 times, well on our way to achieving our goal of three times. We ended Q2 with $49 million in cash, which is sufficient to fund our operations and repurchases of debt and equity. Q2 free cash flow was $15.8 million, 295% positive versus the prior comparable period. Q2 2024 CapEx spend of $8.5 million is down $1.6 million versus the prior year. Based on year-to-date results, we are increasing our full-year EPS guidance range and reaffirming full-year 2024 revenue and adjusted EBITDA guidance at the midpoint as follows: Revenue between $338 million and $353 million, with $345 million at the midpoint. Adjusted EBITDA between $182 million and $194 million, with $188 million at the midpoint. Adjusted EPS guidance range from $5.45- $5.55, with $5.50 at the midpoint. Our estimated share count and non-GAAP income tax rate was 19.3- 19.4 million shares and a tax rate of 20.5%- 22.5%. For additional guidance within the quarter spread of guidance, we are providing Q3 2024 guidance results as follows. Revenues are expected to be between $83.5 million and $87.5 million, with $85.5 million at the midpoint. Adjusted EBITDA between $44.5 million and $47.5 million, with $46 million at the midpoint. Adjusted EPS between $1.25- $1.35, with $1.30 at midpoint. Q3 2024 estimated share count and income tax rates are 19.3-19.4 million shares, and a tax rate of 20.5%-22.5% respectively. This concludes my formal remarks. Now I'd like to turn the call back to the operator for Q&A. Thank you. We will now be conducting a question-and-answer session. In the interest of time, we ask that you please limit yourself to one question. If you would like to ask a question, please press star one on your telephone keypad. A confirmation tone will indicate your line is in the question queue. You may press star two if you would like to remove yourself from the queue. For participants using speaker equipment, it may be necessary to pick up your handset before pressing the star keys. Once again, please press star one if you have a question at this time. One moment, please, while we pull for questions. The first question today is coming from John Tanwanteng from CJS Securities. John, your line is live. Hi, good afternoon. It's actually Charles Strauzer for John, subbing in here. And my question is, with unemployment, you know, slightly teeing up, teeing up a little bit, do you, do you think that the, your healthcare clients might be, you know, starting to be able to staff back up and reduce kind of the, the friction in deployments, or is that still a ways off? You faded in and out. I'm not sure what the issue is with- The audio, yeah. The audio. I know you had something to do about unemployment ticking up, but could you rephrase it again? Yeah, absolutely. Do you think that your healthcare clients might be starting to be able to staff back up and reduce kind of friction in deployments? Oh, got it. Or- Got it. Understood. Yeah. Yeah. Yeah. So, Interesting question. Good question. Appreciate it. Thank you. This is Johnny. So, right now, we don't have any indicators that, that we see clients really finding the talent that they need to, to drive more IT projects. We don't see any changes in that dynamic in the market at all, to be honest. Great. Thank you. Okay. Yes, thank you very much. Thank you. Once again, it will be star one on your phone if you wish to ask a question. That's star one, if you wish to ask a question. Next question is coming from David Larsen from BTIG. David, your line is live. Hi. Can you talk about the deployment process at the VA? How far along are you? Any metrics around, like, how many sites the VA has, how many you're deployed at? When did that start? And then when will you sort of get to sort of a, we'll call it, not a full ramp-up, but a pretty good pace and the total dollars tied to the VA? Just more color there will be very helpful. And how has that situation evolved? Is it improving in terms of access and deployment timing? Thanks very much. Yeah. Hi, David, this is Johnny. Good question. Thank you. I think it's-- we're at a... We can't really say what percentage we're at on the site metric. It's-- They have about 2,200 sites- Right. of what we currently know. But a site can be, you know, a handful of people operating an office at a cemetery, or it can be a huge hospital. So the site is not really a metric that gives us a good indication of volume. It's more about the number of employees, the number of seats that we have, and then beyond that, what applications are these people using? And we don't have a clear inventory of that at the moment. Remember, we are rolling this out in close collaboration with our partner, Accenture Federal Services. They are driving the majority of the rollout at the sites and training the end users. We are the provider of the infrastructure. Right now, like I said in my opening remarks, we're on pace, we're on track with the rollout at what we had expected. But, you know, obviously, there is a tremendous potential within that account. We don't really wanna put a final number on it, because I don't think the VA knows themselves, right? It's a very, very large organization, with hundreds of fax servers, thousands of you know multifunctional devices and machines that they're operating, and they're step-by-step migrating over to the ECFax solution. So, as we go along and as we roll out, we will get a better understanding of how large the total opportunity is, but we're still at the very beginning. And I would just add to what Johnny said, David, that, in terms of the first part of your question, you'll recall it was really about a year ago, literally almost a year ago, September of 2023, when the real rollout started. Because that first phase from March- June, July was really the test cases. And then there was a big bring down meeting to discuss both how those rollouts had been done, the format in which they had proceeded, and alternative ways, because the VA has a similar incentive as we do, which is to see it roll out at a faster pace. And then that resulted in a number of months of going back and forth of alternative structures beyond just bringing a facility online. So the original view was, yes, it would be facility by facility, and eventually, you'd be at 2,200. And while that is still true, and there's been a dramatic acceleration of number of facilities that have access to the service, since a year ago, as Johnny pointed out, that's really. It's only one of really several metrics that matter, because there's, I think, close to a million employees that are within the VA, so that constitutes another block of users, and then you've got embedded applications. And so what we have seen is what I'll call a liberalization of how the rollout is and will take place on a going-forward basis. So we're seeing basically each month, some degree of rollout relative to the previous month, and as a result, increasing traffic on a sequential basis. And so, as Johnny referenced in his remarks, you know, we think $2 million-ish of revenue this year, which is, you know, like an infinite increase versus last year. But I would expect significant growth in that number as we go into 2025, just based on the run rate exit that we'll have at the end of 2024, before you even get to adding new users or new facilities in 2025. So I know that's not the exact quantification you want, but we're not gonna give it to you. Because, as Johnny pointed out, it's very challenging with the VA. I think a lot of times there's just so many different embedded applications and systems and regions, that it's a challenge for them to even come up with what that number is. But I think we have several years of growth relative to where we sit today, in terms of getting to what you might consider to be, meaning, you know, full, not full penetration, but substantial penetration of the VA opportunity. ... Okay. It sounds like things are improving, is what I'm kind of hearing. And then- Yes. Also, when you listen-- Okay, was that a yes? Yes, that was a yes. Okay. Okay, and then also, when you listen to the publicly traded hospitals report, they, they each are consistently saying that, you know, labor shortages are being resolved. They're saying that, inflation rates have improved. Their, their reliance on contract labor has been reduced. Volumes, actually look very good at the publicly traded hospitals, as do the EBITDA margins. I guess, any thoughts on, like, I guess this is similar to that first question, but any thoughts on the, sort of demand level, from the, the hospital market and, and the healthcare facilities that you're working with now? Has there been any improvement? Again, good question. Right now, we're seeing both sides of that coin, right? We see hospitals that are doing very well. I think they are, you know, covering on the clinical side, which is where what you're hearing, is that they're actually hiring that kind of staff. They're still very cost conscious and, trying to manage their bottom line as well. Mm-hmm. We don't see a necessarily increase in the IT staff, which is where we need most of the support. And then you also do see, you know, the flip side of the coin, where you see hospitals that are in distress, right? It's, I mean, very public, probably the Steward Health case. They just filed Chapter Eleven recently. So I think you have both sides of that coin in the healthcare industry. You have the very large ones that are doing well, but you also have the ones that continue to struggle. Now, that's not necessarily bad for us, right? Because they're looking to optimize their costs as well, and we can contribute to that. So we can use that as an opportunity to help them, save some money and, you know, get rid of legacy infrastructure, which is usually costly. But on the labor side, we don't see a lot of improvement at the moment. Okay, that's, that's helpful. This is one more quick one from me. Any comments on the Clarity prior auth solution or Clarity clinical documentation? What sort of uptake rate are you seeing there? Any way to sort of take a stab at total dollar, incremental dollar flow from your clients or in-sell opportunities? Thank you very much. Yeah. So we do see, we do see increased interest in that product line. We have a lot of customer engagement, as I said, particularly in POCs, so we have to go through these motions. It is building backlog on our implementation teams, as we're building out that implementation capacity. But I think it will be, you know, with that large amount of fax revenue that the company has, which is still growing, which we're adding to every quarter, the Clarity contribution on the revenue side is not material at this point. Okay, thanks very much, and congrats on a good quarter. Thank you, David. So before we take any more live questions, Paul, we've got a couple questions that have come in by email, which I'd like to address, and then you can recheck for the queue if there's any other questions that want to come in. So we have a question regarding the SoHo business. It's really a perspective question to 2025 about the expected rate of decline in SoHo in 2025 versus 2024, and how that might be changing, given the increase in our marketing spend. So let me actually answer a question that's maybe even more near term relevant, which is the last two quarters of 2024. Just so everybody understands, we have a certain pace of spend in the first half of 2024 that is substantially lower than the first half of 2023, and some of that was in my prepared remarks, some of that has been noted by Johnny and Jim. We have seen, based on the cohort analysis and based on the marketing programs, the ability to spend incrementally. Now, from a budgetary standpoint or a forecast standpoint, we've assumed an incremental $1 million in each of Q3 and Q4. And as a result, that's particularly in the near term it hit the EBITDA in the Q3 quarter. What I think is important to understand is that is not an authorized amount of spend, right? That's a budgeted amount of spend. The key is really that both the marginal contribution and the average of that spend maintains what we consider to be a strong LTV to CAC. If we see in given programs or chunks of programs, that you just can't spend more beyond a certain limit, we don't intend to spend it. So a lot of the answer to the 25 question, or at least a portion of it, is a function of what will be the sustained level of marketing spend as we exit 2024 and go into 2025. It is our current expectation, and certainly our hope, we can fully spend that $1 million in each of Q3 and Q4. So you should be expecting a lesser decline in the SoHo business in Q3 and Q4. Those are easier comps for us than Q2, which was our toughest comp of the four quarters of this year. As we address the Q3 results on the November call, I think we'll have good insight in terms of what we expect in 2025. I expect a lesser rate of decline in the SoHo business than we saw or are seeing from 2023 to 2024. In terms of quantifying it now, a lot of it will hinge on the exact level of marketing spend. What is that stabilized run rate as we look forward into 2025? The second question had to do with one of capital deployment or CapEx. It's premised on the question of the nearing of refinancing. I would just remind people that we have, as was noted by Jim, you know, $649 million of debt. There are two tranches of that. The 6% notes are due in October 2026, so more than two years away. Although, as the question is premised, I think we will be looking at what our options are, certainly in 2025, or at a minimum, addressing the tranches that'll be maturing in 2026. The second tranche, which is larger, the 6.5s, mature in October 2028. Our CapEx this year has been more front-end weighted, so we've given you a range of $26 million-$30 million for the year. We believe we're gonna come in near the high end of the range for 2024, around $30 million. So you'll see step downs on a sequential basis in Q3 relative to Q2, and Q4 relative to Q3. This is really a budgetary question as it relates to our level of capital investment in 2025. We obviously have not started that process yet. I would say, sitting here today, I don't see any material change in the level of CapEx spend. Could it be, you know, $2 million or $3 million lower or $2 million or $3 million higher? Yes. A lot of it will be the function of what projects are we carrying into 2025, which ones are we green lighting, which ones are we not green lighting? But I actually don't see the amount of CapEx on the margin as being in any way influential in terms of how we think about refinancing either tranche of debt. Paul, back to you if there's any, more live questions. There were no other live questions at this time, Scott. Okay. So we wanna thank all of you for participating in our Q2 earnings call, and look for press releases in terms of various upcoming conferences that we may be participating in. As I just mentioned, we will announce our Q3 results in the first, I think, full week of November, so there'll be a press release as we get closer to the exact date and time. And of course, if any of you have any other questions, you can reach out to us by email or call us as you digest the results. Thank you. Thank you. This does conclude today's conference. You may disconnect at this time, and have a wonderful day. Thank you for your participation.